New drug aims to tackle stubborn high cholesterol and fats
NCT ID NCT07223658
First seen Nov 03, 2025 · Last updated May 10, 2026 · Updated 29 times
Summary
This early-stage study tests a new medicine called ARO-DIMERPA in 78 adults with mixed hyperlipidemia (high cholesterol and high triglycerides). The main goal is to check safety and how well the drug lowers harmful blood fats. Participants receive either the drug or a placebo, and researchers monitor side effects and changes in cholesterol and triglyceride levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERLIPIDEMIA; MIXED are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site 1
RECRUITINGChristchurch, 8011, New Zealand
Conditions
Explore the condition pages connected to this study.